Yesterday, the cofounders of Stripe published a podcast with the CEO of Eli Lilly, Dave Ricks. It’s over 2 hours in length and a great listen for a number of reasons, but one part of the interview really stood out to me as a key piece of information regarding the future of Eli Lilly’s GLP-1 […]
Note: this article will be updated when new information is available. It’s only been about a month since Brenipatide was christened with its nonproprietary name: before then, it was known as LY3537031. Not a whole lot is known about it, but over the past few days, Lilly has submitted a few trial details that are […]
When you lose weight via a caloric deficit, you’ll generally average a ratio of 25% lean mass loss and 75% non-lean mass loss. It’s slightly more complicated than 25% muscle, 75% fat, but for the sake of convenience, we’re just going to say that’s what it is. Preserving muscle during weight loss is essentially all […]
After an analysis of the current GLP-1 RA research landscape, it’s quite clear that retatrutide’s biggest competition is VK2735. However, it’s fair to say that VK2735 is about equal to retatrutide, and for various reasons, I expect retatrutide to dominate the GLP-1 RA market for quite a few years. A quick primer Although there was […]
Peptide researchers routinely depend on Hospira BAC water (30mL) for lyophilized powder reconstitution. Hospira is owned by Pfizer and follows strict standards for its bacteriostatic water; it is difficult and costly to test BAC water, and as such, reliance on the Hospira brand has been high. Unfortunately, an increasing number of counterfeit bottles have been […]
In this article, I’m going to present multiple lines of evidence to explain why I think NA-931, marketed as Bioglutide, doesn’t exist, and that Lloyd L. Tran (CEO of Biomed Industries) has engaged in extensive scientific fraud and plagiarism. I have compelling reasons to believe that Mr. Tran’s primary motive for this fraudulent activity is to […]
Although AusAminos.com is primarily focused on peptides, we’re ultimately agnostic regarding GLP-1 agonist delivery mechanisms. Today, we’re talking about a non-peptide GLP-1 agonist called orforglipron, which is notable for its imminent availability and oral small-molecule mechanism of action, allowing it to be taken as a pill rather than by injection. How does orforglipron compare with […]
You can now buy research ready retatrutide here. This article will be updated as and when new information is made available. So you don’t have to scroll through paragraphs of SEO blog spam, our best estimate for retatrutide availability in Australia is early 2029 for obesity. Drug approval in Australia can take anywhere from 12 […]
If you have zero knowledge of cryptocurrency and you’d like to use it for online purchases, this is the guide for you! I’m going to try and keep things as simple as possible: cryptocurrency can be very complicated, but it can also be easy to use. Understanding different networks and tokens There are thousands of […]